Khandani AH - Search Results

1

Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma Progression.

Brooks SA, Khandani AH, Fielding JR, Lin W, Sills T, Lee Y, Arreola A, Milowsky MI, Wallen EM, Woods ME, Smith AB, Nielsen ME, Parker JS, Lalush DS, Rathmell WK. Brooks SA, et al. Among authors: khandani ah. Clin Cancer Res. 2016 Jun 15;22(12):2950-9. doi: 10.1158/1078-0432.CCR-15-2115. Epub 2016 Jan 19. Clin Cancer Res. 2016. PMID: 26787754 Free PMC article.

2

Lung cancer presenting with a solitary colon metastasis detected on positron emission tomography scan.

Stinchcombe TE, Socinski MA, Gangarosa LM, Khandani AH. Stinchcombe TE, et al. Among authors: khandani ah. J Clin Oncol. 2006 Oct 20;24(30):4939-40. doi: 10.1200/JCO.2006.06.3354. J Clin Oncol. 2006. PMID: 17050879 No abstract available.

3

PET in management of small pulmonary nodules.

Khandani AH, Fielding JR. Khandani AH, et al. Radiology. 2007 Mar;242(3):948-9; author reply 949. doi: 10.1148/radiol.2423060308. Radiology. 2007. PMID: 17325080 No abstract available.

4

Simultaneous FDG PET+/Glut1+ lung and FDG PET-/Glut1- subcarinal lymph node metastases from prostate cancer.

Khandani AH, Funkhouser WK, Feins R, Socinski MA. Khandani AH, et al. Ann Nucl Med. 2009 Aug;23(6):595-7. doi: 10.1007/s12149-009-0264-2. Epub 2009 May 13. Ann Nucl Med. 2009. PMID: 19437096

5

Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography.

Khandani AH, Dunphy CH, Meteesatien P, Dufault DL, Ivanovic M, Shea TC. Khandani AH, et al. Nucl Med Commun. 2009 Aug;30(8):594-601. doi: 10.1097/MNM.0b013e32832cc295. Nucl Med Commun. 2009. PMID: 19536037

6

Positron emission tomography in renal cell carcinoma: an imaging biomarker in development.

Khandani AH, Rathmell WK. Khandani AH, et al. Semin Nucl Med. 2012 Jul;42(4):221-30. doi: 10.1053/j.semnuclmed.2012.02.002. Semin Nucl Med. 2012. PMID: 22681671 Free PMC article. Review.

7

Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenib.

Khandani AH, Cowey CL, Moore DT, Gohil H, Rathmell WK. Khandani AH, et al. Nucl Med Commun. 2012 Sep;33(9):967-73. doi: 10.1097/MNM.0b013e3283561837. Nucl Med Commun. 2012. PMID: 22714005 Clinical Trial.

8

PET/CT with (124)I-cG250: great potential and some open questions.

Khandani AH, Rathmell WK, Wallen EM, Ivanovic M. Khandani AH, et al. AJR Am J Roentgenol. 2014 Aug;203(2):261-2. doi: 10.2214/AJR.14.12490. AJR Am J Roentgenol. 2014. PMID: 25055257 Review.

9

Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study.

Yin Q, Hung SC, Wang L, Lin W, Fielding JR, Rathmell WK, Khandani AH, Woods ME, Milowsky MI, Brooks SA, Wallen EM, Shen D. Yin Q, et al. Among authors: khandani ah. Sci Rep. 2017 Mar 3;7:43356. doi: 10.1038/srep43356. Sci Rep. 2017. PMID: 28256615 Free PMC article.

10

Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinoma.

Yin Q, Hung SC, Rathmell WK, Shen L, Wang L, Lin W, Fielding JR, Khandani AH, Woods ME, Milowsky MI, Brooks SA, Wallen EM, Shen D. Yin Q, et al. Among authors: khandani ah. Clin Radiol. 2018 Sep;73(9):782-791. doi: 10.1016/j.crad.2018.04.009. Epub 2018 May 23. Clin Radiol. 2018. PMID: 29801658 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters